Cancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient’s body.
Browse the full report @ http://orbisresearch.com/reports/index/medipoint-biopsy-devices-global-analysis-and-market-forecasts .
The biopsy devices market is segmented by cancer indication and by the type of biopsy procedure performed. Beyond providing a general analysis and forecast for each device segment in different global regions from 2013-2022, this report offers a more detailed approach by assessing the adoption patterns of the different biopsy procedure types for specific cancer indications in specific geographies.
Place a direct purchase order on this report at http://www.orbisresearch.com/contact/purchase/173031 .
This report and forecast focus on the adoption patterns of biopsy guns, fine needle aspiration (FNA) devices, core needle biopsy (CNB) devices, and vacuum-assisted biopsy (VAB) devices, as well as biopsy forceps and punches in the diagnosis of breast, prostate, lung, liver, colorectal, and thyroid cancers.
Request a sample MediPoint: Biopsy Devices-Global Analysis and Market Forecasts Report
Some Points From List of Figures:
Figure 1 : Biopsy Devices, Global Market Share, 2015 29
Figure 2: VAB, Global Market Share, 2015 31
Figure 3: CNB/FNA, Global Market Share, 2015 32
Figure 4: Global Biopsy Procedure Volume: All Indications, 2013-2022 65
Figure 5: Biopsy Procedure Volume: All Indications, US, 2013-2022 67
Figure 6: Biopsy Procedure Volumes: Prostate, 5EU, 2013-2022 69
Figure 7: Biopsy Procedure Volume: Breast, 5EU, 2013-2022 70
Figure 8: Biopsy Procedure Volume: Lung, 5EU, 2013-2022 71
Figure 9: Biopsy Procedure Volume: Colorectal, 5EU, 2013-2022 72
Figure 10: Biopsy Procedure Volumes: Liver, 5EU, 2013-2022 73
Figure 11: Biopsy Procedure Volume: Thyroid, 5EU, 2013-2022 74
Figure 12: Biopsy Procedure Volume: Prostate, APAC Region, 2013-2022 75
Figure 13: Biopsy Procedure Volume: Breast, APAC Region, 2013-2022 76
Figure 14: Biopsy Procedure Volume: Lung, APAC Region, 2013-2022 77
Figure 15: Biopsy Procedure Volume: Colorectal, APAC Region, 2013-2022 78
Figure 16: Biopsy Procedure Volume: Liver, APAC Region, 2013-2022 79
Figure 17: Biopsy Procedure Volume: Thyroid, APAC Region, 2013-2022 80
Figure 18: Biopsy Procedure Volume: All Cancer Indications, Brazil, 2013-2022 81
Figure 19: Global FNA Device Sales ($m) Forecast, 2013-2022 90
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: firstname.lastname@example.org